Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Virus Like Particles Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Virus Like Particles Market Status and Forecast (2016-2027)
      • 1.3.2 Global Virus Like Particles Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Virus Like Particles Supply by Company

    • 2.1 Global Virus Like Particles Sales Volume by Company
    • 2.2 Global Virus Like Particles Sales Value by Company
    • 2.3 Global Virus Like Particles Price by Company
    • 2.4 Virus Like Particles Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Virus Like Particles Market Status by Category

    • 3.1 Virus Like Particles Category Introduction
      • 3.1.1 Adeno-Associated Virus
      • 3.1.2 HIV
      • 3.1.3 Hepatitis B Virus
      • 3.1.4 Hepatitis C Virus
      • 3.1.5 Others
    • 3.2 Global Virus Like Particles Market by Category
      • 3.2.1 Global Virus Like Particles Sales Volume by Category (2016-2021)
      • 3.2.2 Global Virus Like Particles Sales Value by Category (2016-2021)
      • 3.2.3 Global Virus Like Particles Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Virus Like Particles Market Status by End User/Segment

    • 4.1 Virus Like Particles Segment by End User/Segment
      • 4.1.1 Vaccines
      • 4.1.2 Mycoviruses
      • 4.1.3 Virus Research
      • 4.1.4 Therapeutic and Imaging Agents
      • 4.1.5 Others
    • 4.2 Global Virus Like Particles Market by End User/Segment
      • 4.2.1 Global Virus Like Particles Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global Virus Like Particles Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global Virus Like Particles Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Virus Like Particles Market Status by Region

    • 5.1 Global Virus Like Particles Market by Region
      • 5.1.1 Global Virus Like Particles Sales Volume by Region
      • 5.1.2 Global Virus Like Particles Sales Value by Region
    • 5.2 North America Virus Like Particles Market Status
    • 5.3 Europe Virus Like Particles Market Status
    • 5.4 Asia Pacific Virus Like Particles Market Status
    • 5.5 Central & South America Virus Like Particles Market Status
    • 5.6 Middle East & Africa Virus Like Particles Market Status

    6 North America Virus Like Particles Market Status

    • 6.1 North America Virus Like Particles Market by Country
      • 6.1.1 North America Virus Like Particles Sales Volume by Country (2016-2021)
      • 6.1.2 North America Virus Like Particles Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Virus Like Particles Market Status

    • 7.1 Europe Virus Like Particles Market by Country
      • 7.1.1 Europe Virus Like Particles Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Virus Like Particles Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Virus Like Particles Market Status

    • 8.1 Asia Pacific Virus Like Particles Market by Country
      • 8.1.1 Asia Pacific Virus Like Particles Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Virus Like Particles Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Virus Like Particles Market Status

    • 9.1 Central & South America Virus Like Particles Market by Country
      • 9.1.1 Central & South America Virus Like Particles Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Virus Like Particles Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Virus Like Particles Market Status

    • 10.1 Middle East & Africa Virus Like Particles Market by Country
      • 10.1.1 Middle East & Africa Virus Like Particles Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Virus Like Particles Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Virus Like Particles Manufacturing Cost Analysis
    • 11.5 Virus Like Particles Sales Channel and Distributors Analysis
      • 11.5.1 Virus Like Particles Sales Channel
      • 11.5.2 Virus Like Particles Distributors
    • 11.6 Virus Like Particles Downstream Major Buyers

    12 Global Virus Like Particles Market Forecast by Category and by End User/Segment

    • 12.1 Global Virus Like Particles Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Virus Like Particles Forecast by Category
      • 12.2.1 Global Virus Like Particles Sales Volume Forecast by Category
      • 12.2.2 Global Virus Like Particles Sales Value Forecast by Category
      • 12.2.3 Global Virus Like Particles Price Forecast by Category
    • 12.3 Global Virus Like Particles Forecast by End User/Segment
      • 12.3.1 Global Virus Like Particles Sales Volume Forecast by End User/Segment
      • 12.3.2 Global Virus Like Particles Sales Value Forecast by End User/Segment
      • 12.3.3 Global Virus Like Particles Price Forecast by End User/Segment

    13 Global Virus Like Particles Market Forecast by Region/Country

    • 13.1 Global Virus Like Particles Market Forecast by Region (2022-2027)
      • 13.1.1 Global Virus Like Particles Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Virus Like Particles Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Xiamen Innovax Biotech
      • 14.1.1 Company Information
      • 14.1.2 Virus Like Particles Product Introduction
      • 14.1.3 Xiamen Innovax Biotech Virus Like Particles Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 TechnoVax
      • 14.2.1 Company Information
      • 14.2.2 Virus Like Particles Product Introduction
      • 14.2.3 TechnoVax Virus Like Particles Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Takeda
      • 14.3.1 Company Information
      • 14.3.2 Virus Like Particles Product Introduction
      • 14.3.3 Takeda Virus Like Particles Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 Serum Institute of India
      • 14.4.1 Company Information
      • 14.4.2 Virus Like Particles Product Introduction
      • 14.4.3 Serum Institute of India Virus Like Particles Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Novavax
      • 14.5.1 Company Information
      • 14.5.2 Virus Like Particles Product Introduction
      • 14.5.3 Novavax Virus Like Particles Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Merck
      • 14.6.1 Company Information
      • 14.6.2 Virus Like Particles Product Introduction
      • 14.6.3 Merck Virus Like Particles Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 SWOT Analysis
    • 14.7 MedImmune
      • 14.7.1 Company Information
      • 14.7.2 Virus Like Particles Product Introduction
      • 14.7.3 MedImmune Virus Like Particles Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 SWOT Analysis
    • 14.8 Medicago
      • 14.8.1 Company Information
      • 14.8.2 Virus Like Particles Product Introduction
      • 14.8.3 Medicago Virus Like Particles Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 SWOT Analysis
    • 14.9 GlaxoSmithKline
      • 14.9.1 Company Information
      • 14.9.2 Virus Like Particles Product Introduction
      • 14.9.3 GlaxoSmithKline Virus Like Particles Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 SWOT Analysis
    • 14.10 GeoVax Labs
      • 14.10.1 Company Information
      • 14.10.2 Virus Like Particles Product Introduction
      • 14.10.3 GeoVax Labs Virus Like Particles Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.10.4 SWOT Analysis
    • 14.11 Cytos Biotechnology
    • 14.12 CPL Biologicals
    • 14.13 ANGANY Genetics
    • 14.14 Allergy Therapeutics
    • 14.15 Agilvax

    15 Conclusion

      16 Methodology

      Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Virus Like Particles market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. Global leading players are profiled with their revenue, market share, profit margin, major product portfolio and SWOT analysis. From industry perspective this report analyses supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Virus Like Particles market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

      Segmented by Category
      Adeno-Associated Virus
      HIV
      Hepatitis B Virus
      Hepatitis C Virus
      Others

      Segmented by End User/Segment
      Vaccines
      Mycoviruses
      Virus Research
      Therapeutic and Imaging Agents
      Others

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Xiamen Innovax Biotech
      TechnoVax
      Takeda
      Serum Institute of India
      Novavax
      Merck
      MedImmune
      Medicago
      GlaxoSmithKline
      GeoVax Labs
      Cytos Biotechnology
      CPL Biologicals
      ANGANY Genetics
      Allergy Therapeutics
      Agilvax
      Buy now